Atrial fibrillation (AF or Afib) is the most common cardiac arrhythmia affecting millions worldwide. AF causes the left atrium to fibrillate leading to blood clot formation and increased risk of stroke.
20%-30% of all strokes occur in AF patients
The lifetime risk of getting AF is 1 in 4
AF may be treated with medication, cardioversion or with catheter ablation which is considered the golden standard interventional procedure. In catheter ablation procedures lesions are formed in the left atrium around the pulmonary veins where the irregular electrical signals are coming from. Lesions are created with catheters that deliver uniform energy via direct contact with the tissue leading to its destruction and therefore, blockage of the irregular electrical.
Existing solutions difficult to use
Up to 40% of patients require 2nd procedure
No tissue thickness measurement
No lesion monitoring
No-Contact Guided Ablation
The first product that allows:
Automatic power titration based on tissue thickness
Real-time lesion monitoring